The effect of monoamine oxidase B (MAOB) and catechol-O-methyltransferase (COMT) polymorphisms on levodopa therapy in patients with sporadic Parkinson's disease

200473 citationsJournal Article

Authors

Monika Białecka · Pomeranian Medical University

Marek Droździk · Pomeranian Medical University

Gabriela Kłodowska-Duda · Medical University of Silesia

Krystyna Honczarenko · Pomeranian Medical University

B Gawrońska-Szklarz · Pomeranian Medical University

Grzegorz Opala · Medical University of Silesia

Jan Stankiewicz

Abstract

The results of the study suggest that patients with COMT(L/L) genotype and possibly MAOB genotype A may benefit from more efficient and safer levodopa therapy.

Topics & Keywords

Parkinson's Disease Mechanisms and Treatments Neurological disorders and treatments Autism Spectrum Disorder Research

Publication Details

Published in: Acta Neurologica Scandinavica

Volume 110, Issue 4, pp. 260-266

DOI: 10.1111/j.1600-0404.2004.00315.x

Field-Weighted Citation Impact: 1.26

Command Palette

The effect of monoamine oxidase B (MAOB) and catechol-O-methyltransferase (COMT) polymorphisms on levodopa therapy in patients with sporadic Parkinson's disease

Authors

Abstract

Topics & Keywords

Publication Details